Navigation Links
QED International Associates Announces Quarterly Rebalancing of HealthShares(TM) Indexes (As Revised)
Date:3/20/2008

NEW YORK, March 20 /PRNewswire/ -- QED International Associates Inc., administrator for the HealthShares(TM) Indexes, a series of 20 underlying indexes for the HealthShares(TM) Exchange-Traded Funds, today announced the quarterly rebalancing of the Indexes. The following securities will be added and deleted in the Indexes effective before the opening of trading on NYSE Arca March 24, 2008.

Autoimmune-Inflammation Index (HHA)

Drop

GW Pharmaceuticals, Inc (LSE: GWP.L)

Human Genome Sciences (Nasdaq: HGSI)

Ligand Pharmaceuticals, Inc. (Nasdaq: LGND)

Add

Fornix Biosciences N.V. (Amsterdam: FORBI.AS)

Meda AB (SHSE1: MEDA A)

Mitsubishi Tanabe Pharma Corporation (TSE: 4508)

Cancer Index (HHK)

Drop

Shire PLC (Nasdaq: SHPGY)

Add

Ark Therapeutics Group Plc (LSE: AKT.L)

Cardio Devices Index (HHE)

Drop

Biosphere Medical, Inc. (Nasdaq: BSMD)

Add

Zoll Medical Corp. (Nasdaq: '/>"/>

SOURCE QED International Associates Inc.,
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15

Related biology technology :

1. Spectral announces new findings on the effectiveness of EAA(TM)/Toraymyxin(TM) at the 28th International Symposium on Intensive Care and Emergency Medicine
2. PAREXEL International to Present at Lehman Brothers 11th Annual Global Healthcare Conference
3. China Yingxia International Announces Q4 and FY 2007 Estimates
4. CryoCor Requests International Trade Commission Investigation Into CryoCath for Patent Infringement
5. PAREXEL International to Present at Raymond James 29th Annual Institutional Investors Conference
6. International Confocal Microscopy Working Group Established to Advance Practice of Reflective Confocal Microscopy
7. Bio-Clean International, Inc. to Present at Bluechip Capital Investment Forum
8. QED International Associates Announces Changes to the HealthShares(TM) Dermatology and Wound Care Index
9. IBF Conferences Inc., (International Business Forum) and BioEnterprise Present the 2nd Annual Global Healthcare Investing Conference
10. PAREXEL International Announces 2-For-1 Stock Split
11. Cryo-Cell International, Inc. Reports Results for Fiscal 2007

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/24/2009)...thasbeenmetforpatientswithadvanced-stage,orrecurre...wswire-FirstCall/-AEternaZentarisInc.(NASDAQ: AEZS...ompanyfocusedonendocrinetherapyandoncology,todayan...targetedcytotoxicpeptideconjugate,AEZS-108(formerl...ialcancer.Inapersonalizedhealthcareapproach,thestu...
(Date:11/24/2009)....24/PRNewswire-FirstCall/--GenomicHealth,Inc.(Nasd...th,sExecutiveChairman,willpresentatthe21stAnnualPi...ay,December1,2009at10:00a.m.ET. ,, Toaccessthel...,visittheInvestorRelationssectionofGenomicHealth,s...econnecttothewebsiteatleast15minutespriortothebegi...
(Date:11/24/2009)...ire-FirstCall/--CellTherapeutics,Inc.(CTI)(Nasdaqa...erJaffrayHealthCareConference.Theconferencewillbeh... CTIwillpresentonTuesday,December1at11:00a.m.Easte...presentationwillbeavailableat www.celltherapeutics... , ,PiperJaffrayHealthCareConference,NewYorkPalac...
(Date:11/23/2009)...imensional carbon layer in which the carbon atoms ...honeycomb. Carbon nanotubes are rolled-up sheets o...m graphite. Graphene boasts some very special char...cellent thermal conductor, and reconciles such con...n addition, graphene is impermeable to gases, whic...
Breaking Biology Technology:AEterna Zentaris Announces Positive Results for Phase 2 Study with LHRH-Receptor Targeted Cytotoxic Conjugate AEZS-108 in Endometrial Cancer 2AEterna Zentaris Announces Positive Results for Phase 2 Study with LHRH-Receptor Targeted Cytotoxic Conjugate AEZS-108 in Endometrial Cancer 3AEterna Zentaris Announces Positive Results for Phase 2 Study with LHRH-Receptor Targeted Cytotoxic Conjugate AEZS-108 in Endometrial Cancer 4Genomic Health to Present at Piper Jaffray Health Care Conference 2Polymer with honeycomb structure 2
...l 25 CV Therapeutics,Inc. (Nasdaq: CVTX ) today ...nded March 31, 2008., For the quarter ended March...9 million, or $0.53 per share. This compares to a ... the prior quarter ended December 31, 2007,and $55...er in 2007., For the quarter ended March 31, 2008...
...ntists and Collaborators Publish Study in Science,...bH, the,leading developer of RAFT intervention the...per in Science demonstrating a potential novel str...and other diseases by targeting,discrete sub-compa...nducted,by JADO scientists together with several a...
...lif., April 24 ,Exelixis, Inc. (Nasdaq: EXEL ) an...t and chief executive officer of Exelixis, will pr...ugged Conference at 3:40 p.m. ET/12:40,p.m. PT on ...s updates to,the company,s development pipeline an...ebcast and may be accessed in the Event,Calendar p...
Other Biology Technology:CV Therapeutics Reports 2008 First Quarter Financial Results 2CV Therapeutics Reports 2008 First Quarter Financial Results 3CV Therapeutics Reports 2008 First Quarter Financial Results 4CV Therapeutics Reports 2008 First Quarter Financial Results 5Novel Approach to Treat Alzheimer's and Other Diseases Offered by Targeting Cell Membrane RAFTS 2Novel Approach to Treat Alzheimer's and Other Diseases Offered by Targeting Cell Membrane RAFTS 3Novel Approach to Treat Alzheimer's and Other Diseases Offered by Targeting Cell Membrane RAFTS 4
(Date:11/24/2009)...akened and flabby arteries from collapsing have be...tents are no longer needed -- once the arteries ar...y, doctors had no choice but to leave them in plac...ty,s Department of Biomedical Engineering has deve...ries drugs where they,re needed, then dissolves. ,...
(Date:11/24/2009)...rctica has long held secrets of the earth,s histor...ere has been very little information on the enviro...for millions of years. Now, a team of researchers ...unded to the tune of $10 million dollars by the Na...ottom of things literally. These scientists will ...
(Date:11/23/2009)...rch presents strong evidence that the "synergistic...affic-related pollution and indoor endotoxin cause...her exposure alone. , Environmental health sci...ge of Medicine have shown that children exposed to... indoor endotoxin during early life are six times ...
Breaking Biology News(10 mins):A coating for life 2LSU gets to the bottom of things -- in Antarctica 2Exposure to both traffic, indoor pollutants puts some kids at higher risk for asthma later 2Vyvanse Capsules CII administration through 2 routes demonstrated similar pharmacokinetic profile 59967 1Vyvanse Capsules CII administration through 2 routes demonstrated similar pharmacokinetic profile 59967 2Vyvanse Capsules CII administration through 2 routes demonstrated similar pharmacokinetic profile 59967 3Rotavirus Vaccine Cutting Infection Rates Among Kids 59964 1Rotavirus Vaccine Cutting Infection Rates Among Kids 59964 2Syphilis survey reveals need for accurate testing for early infection 59960 1
...ing environmental study to be published in a prest...y atmospheric emissions will end up in fish in as ...ity of Alberta in Edmonton, Canada, played a key r..., The study concludes that if mercury emissions f...ctivities were to be cut immediately, the amount s...
...CScientists are working to produce cheap, sustaina...gy researchers like California Institute of Techno...materials that mimic the architecture of grass and...gy. , A new podcast looks at how Dr. Lewis and h...nanoparticles into simple, inexpensive everyday pr...
...earchers led by Fei Hu, assistant professor of com...logy, is working to advance the integration of rad... as RFID, into cardiac sensor networks, a new wire...m will also work to enhance the security of the sy...ssibility of identity theft and cyber-terrorism. T...
Other Biology News:New research seeks to enhance quality and security of wireless telemedicine 2
Rabbit Anti-PGC-1 (H-300) Polyclonal Antibody, Unconjugated from Santa Cruz Biotechnology, Inc.
Rat Anti-Mouse VEGF R1 / Flt-1 Monoclonal Antibody, Allophycocyanin Conjugated, Clone 141522 from R&D Systems
Anti-Human Amyloid beta [1-16] Monoclonal Antibody, Unconjugated, Clone 6E10 from Cell Sciences
pCDF-1 Expression System plus Competent Cells from Novagen
Biology Products: